Sana Biotechnology
SANA
SANA
116 hedge funds and large institutions have $808M invested in Sana Biotechnology in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 37 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
5% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 37
1% less funds holding
Funds holding: 117 → 116 (-1)
18% less capital invested
Capital invested by funds: $986M → $808M (-$178M)
Holders
116
Holding in Top 10
3
Calls
$333K
Puts
$123K
Top Buyers
| 1 | +$14.6M | |
| 2 | +$9.28M | |
| 3 | +$5.41M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$4.58M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$3.84M |
Top Sellers
| 1 | -$6.56M | |
| 2 | -$5.52M | |
| 3 | -$1.47M | |
| 4 |
PGP
Prescott General Partners
Boca Raton,
Florida
|
-$1.25M |
| 5 |
Two Sigma Investments
New York
|
-$1.16M |